Epigenetic Reprogramming During Prostate Cancer Progression: A Perspective from Development

Overview

Journal Semin Cancer Biol

Specialty Oncology

Date 2021 Feb 5

PMID 33545340

Citations 12

Authors

Sakshi Goel

Vipul Bhatia

Tanay Biswas

Bushra Ateeq

Affiliations

Soon will be listed here.

Abstract

Conrad Waddington's theory of epigenetic landscape epitomize the process of cell fate and cellular decision-making during development. Wherein the epigenetic code maintains patterns of gene expression in pluripotent and differentiated cellular states during embryonic development and differentiation. Over the years disruption or reprogramming of the epigenetic landscape has been extensively studied in the course of cancer progression. Cellular dedifferentiation being a key hallmark of cancer allow us to take cues from the biological processes involving epigenetic reprogramming in development such as the cellular differentiation and morphogenesis. Here, we discuss the role of epigenetic landscape and its modifiers in cell-fate determination, differentiation and prostate cancer progression. Lately, the emergence of RNA-modifications has also furthered our understanding of epigenetics in cancer. The overview of the epigenetic code regulating androgen signalling, and progression to aggressive neuroendocrine stage of PCa reinforces its gene regulatory functions during the development of prostate gland as well as cancer progression. Additionally, we also highlight the clinical implications of cancer cell epigenome, and discuss the recent advancements in the therapeutic strategies targeting the advanced stage disease.

Citing Articles

From microscopes to molecules: The evolution of prostate cancer diagnostics.

Tao J, Bian X, Zhou J, Zhang M Cytojournal. 2024; 21:29.

PMID: 39391208 PMC: 11464998. DOI: 10.25259/Cytojournal_36_2024.

Promising therapy for neuroendocrine prostate cancer: current status and future directions.

Fei X, Xue J, Wu J, Yang C, Wang K, Ma Q Ther Adv Med Oncol. 2024; 16:17588359241269676.

PMID: 39131727 PMC: 11311189. DOI: 10.1177/17588359241269676.

RAG1 and RAG2 non-core regions are implicated in leukemogenesis and off-target V(D)J recombination in BCR-ABL1-driven B-cell lineage lymphoblastic leukemia.

Yu X, Zhou W, Chen X, He S, Qin M, Yuan M Elife. 2024; 12.

PMID: 39056282 PMC: 11281782. DOI: 10.7554/eLife.91030.

Li Y, Li C, Wu L, Li J, Gan Y, Tan S Heliyon. 2024; 10(10):e30941.

PMID: 38779031 PMC: 11109796. DOI: 10.1016/j.heliyon.2024.e30941.

It Takes Two to Tango: The Interplay between Prostate Cancer and Its Microenvironment from an Epigenetic Perspective.

Zaalberg A, Pottendorfer E, Zwart W, Bergman A Cancers (Basel). 2024; 16(2).

PMID: 38254784 PMC: 10813511. DOI: 10.3390/cancers16020294.

References

Hyun K, Jeon J, Park K, Kim J . Writing, erasing and reading histone lysine methylations. Exp Mol Med. 2017; 49(4):e324. PMC: 6130214. DOI: 10.1038/emm.2017.11. View

Peitzsch C, Cojoc M, Hein L, Kurth I, Mabert K, Trautmann F . An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells. Cancer Res. 2016; 76(9):2637-51. DOI: 10.1158/0008-5472.CAN-15-2116. View

Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

Yoo A, Sun A, Li L, Shcheglovitov A, Portmann T, Li Y . MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011; 476(7359):228-31. PMC: 3348862. DOI: 10.1038/nature10323. View

Chen T, Dent S . Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat Rev Genet. 2013; 15(2):93-106. PMC: 3999985. DOI: 10.1038/nrg3607. View

Pan T . N6-methyl-adenosine modification in messenger and long non-coding RNA. Trends Biochem Sci. 2013; 38(4):204-9. PMC: 3608796. DOI: 10.1016/j.tibs.2012.12.006. View

Mishra R, Haldar S, Suchanti S, Bhowmick N . Epigenetic changes in fibroblasts drive cancer metabolism and differentiation. Endocr Relat Cancer. 2019; 26(12):R673-R688. PMC: 6859444. DOI: 10.1530/ERC-19-0347. View

Jia W, Deshmukh A, Mani S, Jolly M, Levine H . A possible role for epigenetic feedback regulation in the dynamics of the epithelial-mesenchymal transition (EMT). Phys Biol. 2019; 16(6):066004. PMC: 7085921. DOI: 10.1088/1478-3975/ab34df. View

Bedford M, Van Helden P . Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res. 1987; 47(20):5274-6. View

10.

Takayama K, Misawa A, Suzuki T, Takagi K, Hayashizaki Y, Fujimura T . TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression. Nat Commun. 2015; 6:8219. DOI: 10.1038/ncomms9219. View

11.

Cedar H, Bergman Y . Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009; 10(5):295-304. DOI: 10.1038/nrg2540. View

12.

Easwaran H, Johnstone S, Van Neste L, Ohm J, Mosbruger T, Wang Q . A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res. 2012; 22(5):837-49. PMC: 3337430. DOI: 10.1101/gr.131169.111. View

13.

Chen S, Su J, Zhao Z, Shao Y, Dou Y, Li F . DNA Framework-Supported Electrochemical Analysis of DNA Methylation for Prostate Cancers. Nano Lett. 2020; 20(10):7028-7035. DOI: 10.1021/acs.nanolett.0c01898. View

14.

Djupedal I, Ekwall K . Epigenetics: heterochromatin meets RNAi. Cell Res. 2009; 19(3):282-95. DOI: 10.1038/cr.2009.13. View

15.

Zhou L, Li T, Huang Y, Sha J, Sun P, Li D . Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy. Asian J Androl. 2009; 12(2):171-9. PMC: 3739095. DOI: 10.1038/aja.2009.81. View

16.

Zong Y, Huang J, Sankarasharma D, Morikawa T, Fukayama M, Epstein J . Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling. Proc Natl Acad Sci U S A. 2012; 109(50):E3395-404. PMC: 3528570. DOI: 10.1073/pnas.1217982109. View

17.

Peter M, Bilenky M, Isserlin R, Bader G, Shen S, De Carvalho D . Dynamics of the cell-free DNA methylome of metastatic prostate cancer during androgen-targeting treatment. Epigenomics. 2020; 12(15):1317-1332. DOI: 10.2217/epi-2020-0173. View

18.

Zhang S, Wang Y, Jia L, Wen X, Du Z, Wang C . Profiling the long noncoding RNA interaction network in the regulatory elements of target genes by chromatin in situ reverse transcription sequencing. Genome Res. 2019; 29(9):1521-1532. PMC: 6724666. DOI: 10.1101/gr.244996.118. View

19.

Kim E, Cao D, Mahajan N, Andriole G, Mahajan K . ACK1-AR and AR-HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers. NAR Cancer. 2020; 2(3):zcaa018. PMC: 7454006. DOI: 10.1093/narcan/zcaa018. View

20.

Peterson C . Chromatin remodeling: nucleosomes bulging at the seams. Curr Biol. 2002; 12(7):R245-7. DOI: 10.1016/s0960-9822(02)00782-0. View